English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Csl Behring
Carol Ostrow
| Dec 16, 2017
CSL partners with Vitaeris for organ transplant therapy
Carol Ostrow
| Sep 29, 2017
CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman
| Apr 18, 2017
CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman
| Apr 14, 2017
CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman
| Apr 12, 2017
CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
Jeff Gantt
| Dec 18, 2016
Afstyla approved by Health Canada
Amanda Rupp
| Jun 22, 2016
CSL Behring honors 2016 HAE Day with events
Amanda Rupp
| Jun 1, 2016
Afstyla gains FDA approval as hemophilia A treatment
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
